Vanguard Group Inc Pyxis Oncology, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PYXS
# of Institutions
103Shares Held
22.5MCall Options Held
1.37MPut Options Held
42.2K-
Laurion Capital Management LP New York, NY3.63MShares$4.79 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$3.93 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$3.68 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.08MShares$1.43 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.04MShares$1.37 Million0.26% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $46.3M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...